MEBCYTO Apoptosis Kit (Annexin V-FITC Kit)

Apoptosis Detection Kit



The MEBCYTO® Apoptosis Kit (Annexin V-FITC Kit) can identify cells in an earlier stage of apoptosis than assays based on DNA fragmentation. MBLI’s Annexin V apoptosis detection kit is based on the observation that phosphatidylserines (PS) translocate from the inner membrane to the outer membrane during apoptosis. Annexin V binds to PS on the outer membrane. This event can be easily detected using MBLI’s kit using conventional dye-staining along with any streptavidine or avidin-dye reagents.

Learn More about Apoptosis

Target: Apoptosis
Product Type: Apoptosis Kit
Size: 100 Tests
Research Area / Disease: Apoptosis
Conjugate: FITC
Storage Temperature: 4°C
Regulatory Statement: For Research Use Only. Not for use in diagnostic procedures.


Owari, Takuya, et al. “5-Aminolevulinic acid overcomes hypoxia-induced radiation resistance by enhancing mitochondrial reactive oxygen species production in prostate cancer cells.” British Journal of Cancer (2022): 1-14.

Minato, Tomomi, et al. “β-Aminoisobutyric acid, L-BAIBA, protects PC12 cells from hydrogen peroxide-induced oxidative stress and apoptosis via activation of the AMPK and PI3K/Akt pathway.” IBRO Neuroscience Reports 12 (2022): 65-72.

Erdogan, Cihan Suleyman, et al. “Combinatorial effects of melatonin and paclitaxel differ depending on the treatment scheme in colorectal cancer in vitro.” Life Sciences (2022): 120927.

SHIMIZU, So, et al. “Aberrant upregulation of the endogenous PP2A inhibitor CIP2A is vital for myeloma cell growth and survival.” International Journal of Myeloma 12.2 (2022): 14-23.

LI, HIROMI, et al. “Administration of Gapmer-type Antisense Oligonucleotides Targeting γ-Glutamylcyclotransferase Suppresses the Growth of A549 Lung Cancer Xenografts.” Anticancer Research 42.3 (2022): 1221-1227.

Owari, Takuya, et al. “5-Aminolevulinic acid overcomes hypoxia-induced radiation resistance by enhancing mitochondrial reactive oxygen species production in prostate cancer cells.” British Journal of Cancer (2022): 1-14.

Ben-Mordechai, Tamar, et al. “Ablation of CX3CR1-expressing Immune Cells after Radiation Attenuates Tumor Progression and Sensitizes Cancer Cells to S-phase Specific Chemotherapy.” (2022)

Tran, Phuong Xuan, et al. “Potential for reversing miR-634-mediated cytoprotective processes to improve efficacy of chemotherapy against oral squamous cell carcinoma.” Molecular Therapy-Oncolytics 24 (2022): 897-908.

Moyama, Chiami, et al. “Stat5b inhibition blocks proliferation and tumorigenicity of glioblastoma stem cells derived from a de novo murine brain cancer model.” American journal of cancer research 12.3 (2022): 1129.

Takagi, Hiroko, et al. “Fluorizoline Blocks the Interaction between Prohibitin-2 and γ-Glutamylcyclotransferase and Induces p21Waf1/Cip1 Expression in MCF7 Breast Cancer Cells.” Molecular Pharmacology 101.2 (2022): 78-86.

Shai, Ayelet, et al. “Inhibiting mutant KRAS G12D gene expression using novel peptide nucleic acid based antisense: A potential new drug candidate for pancreatic cancer.” Oncology Letters 23.4 (2022): 1-11.

Nakamura, Keiichiro, et al. “ADAR1 and AZIN1 RNA editing function as an oncogene and contributes to immortalization in endometrial cancer.” Gynecologic Oncology 166.2 (2022): 326-333.

Wirawan, Aditya, et al. “A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1Suppressing LSD1 to Target Mesenchymal Phenotype in MPM.” Molecular Cancer Research 20.1 (2022): 127-138.

Kasahara, Yukiyo, et al. “Primate-specific POTE-actin gene could play a role in human folliculogenesis by controlling the proliferation of granulosa cells.” Cell Death Discovery 7.1 (2021): 1-11.

Hirano, Tetsushi, et al. “Neurotoxicity of a pyrethroid pesticide deltamethrin is associated with the imbalance in proteolytic systems caused by mitophagy activation and proteasome inhibition.” Toxicology and Applied Pharmacology 430 (2021): 115723.

Kishikawa, Masahiro, et al. “Augmentation of lenvatinib efficacy by topical treatment of miR-634 ointment in anaplastic thyroid cancer.” Biochemistry and biophysics reports 26 (2021): 101009.

Yoda, Tomoka, et al. “Epo-C12 inhibits peroxiredoxin 1 peroxidase activity.” Bioorganic & Medicinal Chemistry 41 (2021): 116203.

Tanigawa, Seisuke, et al. “Inhibition of Gli2 suppresses tumorigenicity in glioblastoma stem cells derived from a de novo murine brain cancer model.” Cancer Gene Therapy 28.12 (2021): 1339-1352.

Takada, Naoki, et al. “Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells.” Plos one 16.9 (2021): e0257019.

Miari, Reem, et al. “5-aza-2’-deoxycytidine induces apoptosis and inhibits tumour growth in vivo of FaDu cells, a specific HPVnegative HNSCC cell line.” Plos one 16.9 (2021): e0253756.

Anis, Omer, et al. “Cannabis-derived compounds cannabichromene and Δ9-tetrahydrocannabinol interact and exhibit cytotoxic activity against urothelial cell carcinoma correlated with inhibition of cell migration and cytoskeleton organization.” Molecules 26.2 (2021): 465.

Cho, Byoung Ok, et al. “Kushenol C prevents tert-Butyl hydroperoxide and acetaminophen-induced liver injury.” Molecules 26.6 (2021): 1635.

Saeki, Yukihiko, et al. “Modulation of TNFR 1-triggered two opposing signals for inflammation and apoptosis via RIPK 1 disruption by geldanamycin in rheumatoid arthritis.” Clinical Rheumatology 40.6 (2021): 2395-2405.

Shorer Arbel, Yamit, et al. “Proteolysis targeting chimeras for BTK efficiently inhibit B-cell receptor signaling and can overcome ibrutinib resistance in CLL cells.” Frontiers in oncology 11 (2021): 646971.

Kwon, Joon-Cheol, et al. “Physicochemical and biological similarity assessment of LBAL, a biosimilar to adalimumab reference product (Humira®).” Animal Cells and Systems 25.3 (2021): 182-194.

Ding, Lijian, et al. “Metabolomic Characterization of a cf. Neolyngbya Cyanobacterium from the South China Sea Reveals Wenchangamide A, a Lipopeptide with In Vitro Apoptotic Potential in Colon Cancer Cells.” Marine drugs 19.7 (2021): 397.

Ota, Yoko, et al. “Targeting anaplastic lymphoma kinase (ALK) gene alterations in neuroblastoma by using alkylating pyrrole-imidazole polyamides.” Plos one 16.9 (2021): e0257718.

Teramachi, Jumpei, et al. “TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma.” Haematologica 106.5 (2021): 1401.

Raiter, Annat, et al. “A novel role for an old target: CD45 for breast cancer immunotherapy.” Oncoimmunology 10.1 (2021): 1929725.

Sultan M et al. Specific Overexpression of 15-lipoxygenase in Endothelial Cells Promotes Cancer Cell Death in an in Vivo Lewis Lung Carcinoma Mouse Model. Adv Med Sci. 65, 111-119 (2020)

Liu X et al. Activation of the IRE1α Arm, but Not the PERK Arm, of the Unfolded Protein Response Contributes to Fumonisin B1-Induced Hepatotoxicity. Toxins (Basel). 12, 55 (2020)

Fuchigami T et al. Discovery of Inner Centromere Protein-Derived Small Peptides for Cancer Imaging and Treatment Targeting Survivin. Cancer Sci. 111, 1357-1366 (2020)

Bar-Shalom R et al. Inula Viscosa Extract Inhibits Growth of Colorectal Cancer Cells in vitro and in vivo Through Induction of Apoptosis. Front Oncol. 9, 227 (2019)

Aihara KI et al. Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity. Br J Haematol. 180, 246-258 (2019)

Machihara K, Namba T. BAP31 Inhibits Cell Adaptation to ER Stress Conditions, Negatively Regulating Autophagy Induction by Interaction with STX17. Cells. 8, E1350 (2019)

Hiraishi N et al. Extract of Lactobacillus plantarum strain 06CC2 induces JNK/p38 MAPK pathway-mediated apoptosis through endoplasmic reticulum stress in Caco2 colorectal cancer cells. Biochem Biophys Rep. 20, 100691 (2019)

Mikami D et al. β-Hydroxybutyrate enhances the cytotoxic effect of cisplatin via the inhibition of HDAC/survivin axis in human hepatocellular carcinoma cells. J Pharmacol Sci. 142, 1-8 (2019)

Gokita K et al. Therapeutic Potential of LNP-Mediated Delivery of miR-634 for Cancer Therapy. Mol Ther Nucleic Acids. 19, 330-338 (2019)

Jang WJ et al. Anticancer activity of paroxetine in human colon cancer cells: Involvement of MET and ERBB3. J Cell Mol Med. 23, 1106-1115 (2019)

Zhang E et al. The functional role of Bax/Bak in palmitate-induced lipoapoptosis. Food Chem Toxicol. 123, 268-274 (2019)

Abaev-Schneiderman E et al. SETD3 is a positive regulator of DNA-damage-induced apoptosis. Cell Death Dis. 10, 74 (2019)

Mikami D et al. β-Hydroxybutyrate enhances the cytotoxic effect of cisplatin via the inhibition of HDAC/survivin axis in human hepatocellular carcinoma cells. J Pharmacol Sci. 142, 1-8 (2019)

Fu Y et al. Dasatinib reduces 5-Fu-triggered apoptosis in colon carcinoma by directly modulating Src-dependent caspase-9 phosphorylation. Cell Death Discov. 4, 61 (2018)

Miller M, Tshuva EY. Synthesis of Pure Enantiomers of Titanium(IV) Complexes with Chiral Diaminobis(phenolato) Ligands and Their Biological Reactivity. Sci Rep. 8, 9705 (2018)

Kobayashi M et al. A short-chain fatty acid, propionate, enhances the cytotoxic effect of cisplatin by modulating GPR41 signaling pathways in HepG2 cells. Oncotarget 9, 31342-31354 (2018)

Nguyen PT et al. Interaction between N-cadherin and decoy receptor-2 regulates apoptosis in head and neck cancer. Oncotarget 9, 31516-31530 (2018)

Shteingauz A et al. AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields). Cell Death Dis. 9, 1074 (2018)

Barbati C et al. TNFα expressed on the surface of microparticles modulates endothelial cell fate in rheumatoid arthritis. Arthritis Res Ther. 20, 273 (2018)

Enomoto, Atsushi, Naoki Kido, Michihiko Ito, Nobuhiko Takamatsu, and Kiyoshi Miyagawa. “Serine-Threonine Kinase 38 Is Regulated by Glycogen Synthase Kinase-3 and Modulates Oxidative Stress-induced Cell Death.” Free Radical Biology and Medicine 52.2 (2012): 507-15.

Enomoto, Atsushi, Takemichi Fukasawa, Nobuhiko Takamatsu, Michihiko Ito, Akinori Morita, Yoshio Hosoi, and Kiyoshi Miyagawa. “The HSP90 Inhibitor 17-allylamino-17-demethoxygeldanamycin Modulates Radiosensitivity by Downregulating Serine/threonine Kinase 38 via Sp1 Inhibition.” European Journal of Cancer 49.16 (2013): 3547-558.


  1. Nakamura, K., et al., Ann. Onc. 20, 63-70 (2009)
  2. Ohara, M., et al., Infect. Immune. 76, 4783-4791 (2008)
  3. Oikawa, Y., et al., J. Biol. Chem. 283, 14242-14247 (2008)
  4. Olmeda, D., et al., Cancer Res. 67, 11721-11731 (2007)
  5. Orbach, A., et al., J. Immunol. 179, 7287-7294 (2007)
  6. Ogawa, T., et al., Cancer Res. 65, 9771-9778 (2005)
  7. Kimura, A., et al., Int. Immunol. 16, 991-999 (2004)
  8. Kashio, Y., et al., J. Immunol. 170, 3631-3636 (2003)
  9. Takahashi, A., et al., Clin. Cancer Res. 7, 74-80 (2001)
  10. Kashii, Y., et al., Blood 96, 941-949 (2000)
  11. van Engeland, M., et al., Cytometry 24, 131-139 (1996)
  12. Vermes, I., et al., J. Immunol. Methods 184, 39-51 (1995)
  13. Fadok, V. A., et al., J. Immunol. 148, 2207-2216 (1992)
Code 4700
Product Type Apoptosis Kit
Size 100 Tests